Glenmark Pharmaceuticals Share Price
Know More₹1,670.90 39.20 (2.40%)
04:01 PM, 13-Jun-2025₹1,669.90 30.30 (1.85%)
03:53 PM, 13-Jun-2025BSE : 532296
NSE : GLENMARK
Sector : Health care
ISIN Code : INE935A01035
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 13-Jun-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 47,153 |
Traded Value (₹ Cr) | 2.77 |
Volume (Shares) | 16,580 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,830.05 |
52-Week High Date | 15-Oct-2024 |
52-Week Low (₹) | 1,183.50 |
52-Week Low Date | 12-Jun-2024 |
All Time High (₹) | 1,830.05 |
All Time High Date | 15-Oct-2024 |
All Time Low (₹) | 1.89 |
All Time Low Date | 10-Feb-2000 |
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd News
Glenmark Pharma. Announcement
Glenmark Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 47,125 |
| EPS - TTM (₹) [C] | 46.71 |
| P/E Ratio (X) [C] | 35.75 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 250.00 |
| Latest Dividend Date | 13-Sep-2024 |
| Dividend Yield (%) | 0.15 |
| Book Value Share (₹) [C] | 313.59 |
| P/B Ratio (₹) [C] | 5.33 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund (G) | 1279.13 | 87,78,612 | 1.60 |
| HDFC Mid-Cap Opportunities Fund (IDCW) | 1279.13 | 87,78,612 | 1.60 |
| HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 1279.13 | 87,78,612 | 1.60 |
| HDFC Mid-Cap Opportunities Fund - Direct (G) | 1279.13 | 87,78,612 | 1.60 |
| Mirae Asset Large & Midcap Fund - Regular (G) | 482.74 | 33,13,007 | 1.22 |
| Mirae Asset Large & Midcap Fund - Direct (G) | 482.74 | 33,13,007 | 1.22 |
| Mirae Asset ELSS Tax Saver Fund - Regular (G) | 391.95 | 26,89,916 | 1.53 |
| Mirae Asset ELSS Tax Saver Fund - Regular (IDCW) | 391.95 | 26,89,916 | 1.53 |
| Mirae Asset ELSS Tax Saver Fund - Direct (G) | 391.95 | 26,89,916 | 1.53 |
| Mirae Asset ELSS Tax Saver Fund - Direct (IDCW) | 391.95 | 26,89,916 | 1.53 |
Load more
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 27-Dec-2024 | Geojit Financial Services | Accumulate | 1,720 | |
| 28-May-2024 | Edelweiss Securities | Hold | 1,200 |
Stock Strength
| Today's Low/High (₹) | 1,605.00 1,674.00 |
| Week Low/High (₹) | 1,563.90 1,674.00 |
| Month Low/High (₹) | 1,370.00 1,674.00 |
| Year Low/High (₹) | 1,182.50 1,831.00 |
| All time Low/High (₹) | 1.89 1,831.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 5.03% | 5.01% | -1.30% | -1.14% |
| 1 Month | 17.88% | 17.81% | -0.04% | 0.57% |
| 3 Month | 18.92% | 18.84% | 9.87% | 10.36% |
| 6 Month | 10.06% | 10.00% | -1.24% | -0.20% |
| 1 Year | 36.29% | 36.34% | 5.61% | 5.64% |
| 3 Year | 344.36% | 344.83% | 53.50% | 56.70% |
Company Info
Company Information
Chairman & Managing Director : Glenn Saldanha
Executive Director (Corporate) : Cheryl Pinto
Non Executive Director : B E Saldanha
Independent Non Exe. Director : Rajesh Desai.
Independent Non Exe. Director : Sona Saira Ramasastry
Independent Non Exe. Director : Dipankar Bhattacharjee
Independent Non Exe. Director : V R Iyer
Additional Director : Pradeep Kumar Sinha
Additional Director & WTD & ED : Anurag Mantri
Registered Office: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road,Mumbai,Maharashtra-400026 Ph: 91-22-40189999
FAQs about Glenmark Pharmaceuticals Ltd
1. What's the Glenmark Pharmaceuticals Ltd share price today?
Glenmark Pharmaceuticals Ltd share price was Rs 1,670.90 at 04:01 PM IST on 13th Jun 2025. Glenmark Pharmaceuticals Ltd share price was up by 2.40% over the previous closing price of Rs 1,631.70. Glenmark Pharmaceuticals Ltd share price trend:
- Last 1 Month: Glenmark Pharmaceuticals Ltd share price moved up by 17.88% on BSE.
- Last 3 Months: Glenmark Pharmaceuticals Ltd share price moved up by 18.92% on BSE.
- Last 12 Months: Glenmark Pharmaceuticals Ltd share price moved up by 36.29% on BSE.
- Last 3 Years: Glenmark Pharmaceuticals Ltd share price moved up by 344.36% on BSE.
2. How can I quickly analyse the performance of the Glenmark Pharmaceuticals Ltd stock?
The performance of the Glenmark Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 35.75
- Price to book value ratio is 5.33
- Dividend yield of 0.15
- The EPS (trailing 12 months) of the Glenmark Pharmaceuticals Ltd stock is Rs 46.71
3. What is the market cap of Glenmark Pharmaceuticals Ltd?
Glenmark Pharmaceuticals Ltd has a market capitalisation of Rs 47,153 crore.
4. What is Glenmark Pharmaceuticals Ltd's 52-week high/low share price?
The Glenmark Pharmaceuticals Ltd’s 52-week high share price is Rs 1,830.05 and 52-week low share price is Rs 1,183.50.
5. Is the Glenmark Pharmaceuticals Ltd profitable?
On a consolidated basis, Glenmark Pharmaceuticals Ltd reported a profit of Rs 4.38 crore on a total income of Rs 3,267.89 crore for the quarter ended 2025. For the year ended 2024, Glenmark Pharmaceuticals Ltd had posted a loss of Rs -1,433.52 crore on a total income of Rs 11,813.10 crore.
6. Which are Glenmark Pharmaceuticals Ltd’s peers in the Health care sector?
Glenmark Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Abbott India, Alkem Lab, Glaxosmi. Pharma, Glenmark Pharma., Biocon, Cohance Life, Laurus Labs.
7. Who owns how much in Glenmark Pharmaceuticals Ltd?
Key changes to the Glenmark Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Glenmark Pharmaceuticals Ltd has gone up to 46.65 per cent as of Mar 2025 from 46.65 per cent as of Jun 2024.
